Net profit of Biocon rose 10.97% to Rs 187.10 crore in the quarter ended December 2021 as against Rs 168.60 crore during the previous quarter ended December 2020. Sales rose 17.06% to Rs 2174.20 crore in the quarter ended December 2021 as against Rs 1857.40 crore during the previous quarter ended December 2020.
| Particulars | Quarter Ended | ||
| ? | Dec. 2021 | Dec. 2020 | % Var. |
| Sales | 2174.20 | 1857.40 | 17 |
| OPM % | 20.28 | 21.47 | – |
| PBDT | 474.60 | 421.80 | 13 |
| PBT | 268.90 | 235.50 | 14 |
| NP | 187.10 | 168.60 | 11 |
Powered by Capital Market – Live News
Related Tags
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016, BSE Enlistment Number (RA): 5016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
